Kiichi Adachi
Chief Executive Officer at KRINGLE PHARMA, INC.
Net worth: 271 545 $ as of 2024-04-29
Network origin in Kiichi Adachi first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 6 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kiichi Adachi via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CARNA BIOSCIENCES, INC. | Biotechnology | President | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| MEDINET CO., LTD. | Biotechnology | Director/Board Member | |
| Kyoto University | College/University | Doctorate Degree | |
| Tokyo Institute of Technology | College/University | Graduate Degree | |
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services CarnaBio USA, Inc. provides biologicals and allied products. The company is headquartered in Natick, MA. | Medical Distributors | Director/Board Member | |
ProbeX, Inc.
 ProbeX, Inc. Medical/Nursing ServicesHealth Services Part of Carna Biosciences, Inc., ProbeX, Inc. is a Japanese company that develops, manufactures, and distributes molecular imaging probe reagents. The company is based in Tokyo, Japan. ProbeX was acquired by Carna Biosciences, Inc. from Life Science Management, Inc. on October 01, 2013 for $2.82 million. | Medical/Nursing Services | President | |
KinoPharma, Inc.
 KinoPharma, Inc. Pharmaceuticals: MajorHealth Technology KinoPharma, Inc. manufactures pharmaceutical products. It deals with the research and development of protein phosphorylation enzyme and low molecular clinical drugs. The company was founded by Masatoshi Hagiwara on April 11, 2005 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
PharmaBio Corp.
 PharmaBio Corp. BiotechnologyHealth Technology PharmaBio Corp. provides manufacturing and consulting company specializing in cellular and tissue based products. It offers of cell-based investigational new drugs, various contract testing and inspections including microbial safety testing of cells, specimen storage operations, development, manufacturing and marketing of clean room consumables and various equipment. The company was founded in April 1978 and is headquartered in Nagoya, Japan. | Biotechnology | Director/Board Member | |
HuLA immune, Inc.
 HuLA immune, Inc. Pharmaceuticals: MajorHealth Technology HuLA immune, Inc. is a Japanese company that provides immune cell therapy for cancer treatment. The company is based in Tokyo, Japan. The text in the company's description appears to be a mix of non-English languages, including British English and Japanese. It was founded in 2017 and the CEO is Yasuhiro Shindo. | Pharmaceuticals: Major | Director/Board Member | |
| GenAhead Bio, Inc. | Director/Board Member | ||
| MyMetagenome Co. Ltd. | Director/Board Member |
Statistics
International
| Japan | 12 |
| United States | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Distribution Services | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 15 |
| Corporate Officer/Principal | 3 |
| Chief Administrative Officer | 2 |
| Investor Relations Contact | 2 |
| President | 2 |
Most connected contacts
- Stock Market
- Insiders
- Kiichi Adachi
- Company connections
